These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8357163)

  • 1. Stereo view of conformation and myasthenogenicity in synthetic peptides of acetylcholine receptor alpha-subunit.
    Takamori M
    Ann N Y Acad Sci; 1993 Jun; 681():168-71. PubMed ID: 8357163
    [No Abstract]   [Full Text] [Related]  

  • 2. Conformational modification enhances myasthenogenicity in synthetic peptide of acetylcholine receptor alpha-subunit.
    Takamori M; Okumura S; Komai K; Satake R
    J Neurol Sci; 1990 Nov; 99(2-3):219-27. PubMed ID: 2086725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myasthenogenicity in the main immunogenic region of acetylcholine receptor as modified by conformational design: an approach to antigenic synthetic peptides.
    Takamori M; Hamada T; Okumura S
    J Neurol Sci; 1992 Jun; 109(2):182-7. PubMed ID: 1634900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental myasthenia gravis in congenic mice. Sequence mapping and H-2 restriction of T helper epitopes on the alpha subunits of Torpedo californica and murine acetylcholine receptors.
    Bellone M; Ostlie N; Lei S; Conti-Tronconi BM
    Eur J Immunol; 1991 Oct; 21(10):2303-10. PubMed ID: 1680694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-dimensional location of the main immunogenic region of the acetylcholine receptor.
    Beroukhim R; Unwin N
    Neuron; 1995 Aug; 15(2):323-31. PubMed ID: 7544140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural characterization of the main immunogenic region of the Torpedo acetylcholine receptor.
    Morell SW; Trinh VB; Gudipati E; Friend A; Page NA; Agius MA; Richman DP; Fairclough RH
    Mol Immunol; 2014 Mar; 58(1):116-31. PubMed ID: 24333757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic peptide of human acetylcholine receptor alpha-subunit sequence 125-147 (methionine 144), a more potent autoantigen than its norleucine 144 analog.
    Lennon VA; Huang ZX; McCormick DJ; Griesmann GE; Fujii N; Lambert EH
    Ann N Y Acad Sci; 1988; 540():516-9. PubMed ID: 2462827
    [No Abstract]   [Full Text] [Related]  

  • 8. Epitope-specific suppression of antibody response in experimental autoimmune myasthenia gravis by a monomethoxypolyethylene glycol conjugate of a myasthenogenic synthetic peptide.
    Atassi MZ; Ruan KH; Jinnai K; Oshima M; Ashizawa T
    Proc Natl Acad Sci U S A; 1992 Jul; 89(13):5852-6. PubMed ID: 1378618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human acetylcholine receptor presentation in myasthenia gravis. DR restriction of autoimmune T epitopes and binding of synthetic receptor sequences to DR molecules.
    Manfredi AA; Yuen MH; Moiola L; Protti MP; Conti-Tronconi BM
    J Immunol; 1994 Apr; 152(8):4165-74. PubMed ID: 7511671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myasthenogenicity of a human acetylcholine receptor alpha-subunit peptide: morphology and immunology.
    Matsuo H; Tsujihata M; Satoh A; Takeo G; Yoshimura T; Nagataki S
    Muscle Nerve; 1992 Mar; 15(3):282-7. PubMed ID: 1372965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specificity of the T cell immune response to acetylcholine receptor in experimental autoimmune myasthenia gravis. Response to subunits and synthetic peptides.
    Fujii Y; Lindstrom J
    J Immunol; 1988 Mar; 140(6):1830-7. PubMed ID: 2450133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of experimental autoimmune myasthenia gravis by major histocompatibility complex class II competitor peptides results not only in a suppressed but also in an altered immune response.
    Wauben MH; Hoedemaekers AC; Graus YM; Wagenaar JP; van Eden W; de Baets MH
    Eur J Immunol; 1996 Dec; 26(12):2866-75. PubMed ID: 8977279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular anatomy of an autoantigen: T and B epitopes on the nicotinic acetylcholine receptor in myasthenia gravis.
    Manfredi AA; Protti MP; Bellone M; Moiola L; Conti-Tronconi BM
    J Lab Clin Med; 1992 Jul; 120(1):13-21. PubMed ID: 1377215
    [No Abstract]   [Full Text] [Related]  

  • 14. T cell epitopes in experimental autoimmune myasthenia gravis of the rat: strain-specific epitopes and cross-reaction between two distinct segments of the alpha chain of the nicotinic acetylcholine receptor (Torpedo californica).
    Zhang Y; Barkas T; Juillerat M; Schwendimann B; Wekerle H
    Eur J Immunol; 1988 Apr; 18(4):551-7. PubMed ID: 2452743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and characterization of a 39 amino acid peptide mimic of the main immunogenic region of the Torpedo acetylcholine receptor.
    Trinh VB; Foster AJ; Fairclough RH
    Mol Immunol; 2014 May; 59(1):79-90. PubMed ID: 24491490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of experimental autoimmune myasthenia gravis by synthetic peptides of the acetylcholine receptor.
    Souroujon MC; Carmon S; Fuchs S
    Ann N Y Acad Sci; 1993 Jun; 681():332-4. PubMed ID: 8357185
    [No Abstract]   [Full Text] [Related]  

  • 17. T-helper epitopes on human nicotinic acetylcholine receptor in myasthenia gravis.
    Moiola L; Protti MP; Manfredi AA; Yuen MH; Howard JF; Conti-Tronconi BM
    Ann N Y Acad Sci; 1993 Jun; 681():198-218. PubMed ID: 7689306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 17-Mer self-peptide of acetylcholine receptor binds to B cell MHC class II, activates helper T cells, and stimulates autoantibody production and electrophysiologic signs of myasthenia gravis.
    Yoshikawa H; Lambert EH; Walser-Kuntz DR; Yasukawa Y; McCormick DJ; Lennon VA
    J Immunol; 1997 Aug; 159(3):1570-7. PubMed ID: 9233656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel immunotoxin: a fusion protein consisting of gelonin and an acetylcholine receptor fragment as a potential immunotherapeutic agent for the treatment of Myasthenia gravis.
    Hossann M; Li Z; Shi Y; Kreilinger U; Büttner J; Vogel PD; Yuan J; Wise JG; Trommer WE
    Protein Expr Purif; 2006 Mar; 46(1):73-84. PubMed ID: 16230023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinant selection in murine experimental autoimmune myasthenia gravis. Effect of the bm12 mutation on T cell recognition of acetylcholine receptor epitopes.
    Infante AJ; Thompson PA; Krolick KA; Wall KA
    J Immunol; 1991 May; 146(9):2977-82. PubMed ID: 1707927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.